Using ultrasound to improve diagnosis and treatment of disorders of consciousness

Window On the Brain: Diagnostic, Therapeutic, and Prognostic Sonication of Patients With Disorders of Consciousness

Not applicable Interventional Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06693492

This study is trying to see if using ultrasound can help doctors better diagnose and treat patients with severe brain injuries who have different levels of consciousness.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment100 (estimated)
Ages18 Years to 80 Years
SexAll
SponsorFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Academic / other
Locations4 sites (Crotone, Calabria and 3 other locations)
Trial IDNCT06693492 on ClinicalTrials.gov

What this trial studies

This study aims to enhance the diagnosis and treatment of Disorders of Consciousness (DOC) by utilizing ultrasound techniques. It focuses on patients with severe acquired brain injuries who exhibit varying levels of consciousness, from Unresponsive Wakefulness Syndrome to Minimally Conscious State. The research will explore both the structural and functional aspects of the brain using ultrasound, which is a low-cost and less invasive alternative to traditional neuroimaging methods. By providing real-time data on brain functioning and morphology, the study seeks to improve patient management and identify new therapeutic options.

Who should consider this trial

Good fit: Ideal candidates are adults aged 18-65 with an established diagnosis of DOC following severe acquired brain injury.

Not a fit: Patients with a history of psychiatric or neurological disorders, ongoing mechanical ventilation, or contraindications to MRI may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could lead to better diagnosis and treatment options for patients with disorders of consciousness.

How similar studies have performed: While limited evidence exists for ultrasound techniques in this context, one registered trial is exploring their effectiveness, indicating a novel approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Aim 1

Inclusion criteria:

* an established diagnosis of DOC (UWS or MCS according to the CRS-R criteria and/or a CRS-R total score ≤22) following severe acquired brain injury;
* age\>18 years old;
* written informed consent obtained from each patient's representative.

Exclusion criteria:

* previous psychiatric, neurological, or drug abuse history;
* on-going mechanical ventilation.

From the population enrolled for aim 1, we plan to select ten patients

Inclusion criteria:

* 18\<age\<65 years;
* medical stability over the previous 30 days;
* presence of the following US variables: low brain stiffness, high elasticity, and adequate level of tissue perfusion;
* written informed consent obtained from each patient's representative;
* structural integrity of both thalami as assessed by MRI.

Exclision criteria:

* contraindications to MRI examination;
* presence of decompressive craniectomy or cranioplasty performed within 30 days;
* presence of epileptogenic features on the EEG and/or drug resistant epileptic crisis history;
* presence of severe muscoloskeletal impairments which are likely to interfere with the correct positioning required for the intervention.

Where this trial is running

Crotone, Calabria and 3 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Disorders of Consciousnessdisorders of consciousnessultrasoundneuromodulationminimally conscious statevegetative stateunresponsive wakefulness syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.